Safety and activity of sunitinib in elderly patients (75 years or more) with metastatic renal cell carcinoma: Results of retrospective study in Paoli-Calmettes Cancer Institute in France.

e15506 Background: Actual tolerability of cancer treatment is still poorly documented in elderly patients. Recently some retrospective reviews have been carried out to evaluate tolerability and eff...